The MWV technology, which was developed following consultation with European physicians and patients earlier this year, aims to provide users with a portable and discrete way of carrying medications.
According to healthcare director, David Spackman, the firm’s "Research showed that consumers often take medication when they are on the go. It's common for them to put a couple pills in a pocket or purse for the day.
“Consumers don't want it to be obvious to others when they take medication in public, so we developed a packaging solution that is easy to open, discrete and small enough to carry around, without having to leave the medication information and dosing instructions behind."
MWV’s compliance pack offering
A recent study in the US suggested that 50 to 60 per cent of patients with chronic illnesses fail to adhere to their medications, which reduces therapeutic efficacy and costs the health care system around $170bn (€125bn) annually.
While the drug industry has focused on improving therapeutic efficacy, the packaging sector’s role in the battle against poor compliance has been to improve the way medications are delivered and carried.
These efforts have been an important driver for MWV over the last few years. In July good adherence pack sales and profits growth helped the firm to a positive set of Q2 financials, despite a 16 per cent drop in sales for the period.
Speaking at the time, company spokesperson Alison Von Puschndorf told in-PharmaTechnologist that MWV “believes that there is tremendous value in healthcare delivery solutions that promote adherence.”